ezetimibe has been researched along with Hypertension in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (20.83) | 29.6817 |
| 2010's | 15 (62.50) | 24.3611 |
| 2020's | 4 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Amarenco, P; Bruckert, E; Charles, H; Giroud, M; Kim, JS; Labreuche, J; Lavallée, PC; Lee, BC; Mahagne, MH; Meseguer, E; Nighoghossian, N; Steg, PG; Vicaut, É | 1 |
| Nussbaumerová, B | 1 |
| Ahn, Y; Chae, IH; Hong, SJ; Hong, TJ; Kang, DH; Kim, BK; Kim, H; Kim, HS; Kim, MC; Kim, MH; Kim, SH; Kim, SY; Kim, W; Rhee, MY | 1 |
| Du, M; Wang, Q; Wang, T; Zhu, S | 1 |
| Jaffa, FM; Johnson, E; Kalyani, RR; Shubrook, JH; Skolnik, N | 1 |
| Choby, B | 1 |
| Bang, CN; Boman, K; Devereux, RB; Egstrup, K; Greve, AM; Nienaber, C; Okin, PM; Ray, S; Rossebø, AB; Wachtell, K | 1 |
| Cabrera Mateos, JL; García Díaz, E; Morera Porras, ÓM; Ramírez Medina, D | 1 |
| Gerdts, E; Gohlke-Bärwolf, C; Jander, N; Minners, J; Pedersen, TR; Ray, S; Wachtell, K | 1 |
| Coffman, CJ; Crowley, MJ; Edelman, D; Fredrickson, SK; Jeffreys, AS; Melnyk, SD; Ostroff, JL | 1 |
| Drozd, VIu; Haĭdychuk, VS; Khukhlina, OS; Kosar, LIu; Mandryk, OIe | 1 |
| Han, SH; Hayashi, T; Kim, EY; Koh, KK; Lee, Y; Oh, PC; Park, YM; Sakuma, I; Shin, EK | 1 |
| Boman, K; Greve, AM; Kesäniemi, YA; Nielsen, OW; Nienaber, CA; Olsen, MH; Pedersen, TR; Sabbah, M; Sajadieh, A; Wachtell, K; Willenheimer, R | 1 |
| Sundermeyer, M; Veeraputhiran, M | 1 |
| Borrego Domínguez, JM; Guisado Rasco, A; Lage Gallé, E; Martínez Martínez, A; Mogollón Jiménez, MV; Sánchez Brotons, JA; Sobrino Márquez, JM | 1 |
| Cramariuc, D; Gerdts, E; Rieck, AE; Tuseth, N; Wachtell, K | 1 |
| Cramariuc, D; Gerdts, E; Gohlke-Bärwolf, C; Lund, BP; Rieck, AE; Rossebø, AB | 1 |
| Abt, M; Derks, M; Phelan, M | 1 |
| Hu, FB | 1 |
| Baulmann, J; Schunkert, H | 1 |
| Boman, K; Cramariuc, D; Gerdts, E; Gohlke-Bärwolf, C; Lønnebakken, MT; Rieck, ÅE; Rossebø, AB; Staal, EM | 1 |
| SoRelle, R | 1 |
| Ballantyne, CM | 1 |
| Bissonnette, S; Boukas, S; Habib, R; Sampalis, JS | 1 |
3 review(s) available for ezetimibe and Hypertension
| Article | Year |
|---|---|
Diabetes Update: Prevention and Management of Diabetes Complications.
Topics: Anticholesteremic Agents; Antihypertensive Agents; Cardiovascular Diseases; Depression; Diabetes Complications; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Dyslipidemias; Ezetimibe; Gastroparesis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension | 2017 |
Natural history of mild and of moderate aortic stenosis-new insights from a large prospective European study.
Topics: Anticholesteremic Agents; Aortic Valve; Aortic Valve Stenosis; Azetidines; Calcinosis; Comorbidity; Disease Progression; Drug Therapy, Combination; Ezetimibe; Humans; Hypertension; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Severity of Illness Index; Simvastatin; Treatment Outcome | 2013 |
Rationale for targeting multiple lipid pathways for optimal cardiovascular risk reduction.
Topics: Aged; Anticholesteremic Agents; Azetidines; Cholesterol, LDL; Coronary Disease; Drug Therapy, Combination; Dyslipidemias; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Risk Factors | 2005 |
9 trial(s) available for ezetimibe and Hypertension
| Article | Year |
|---|---|
Intracranial Hemorrhage in the TST Trial.
Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Anticoagulants; Cholesterol, LDL; Coronary Artery Disease; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Incidence; Intracranial Arteriosclerosis; Intracranial Hemorrhages; Ischemic Attack, Transient; Ischemic Stroke; Male; Middle Aged; Predictive Value of Tests; Risk Factors; Secondary Prevention; Young Adult | 2022 |
A Randomized, Multicenter, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a Quadruple Combination of Amlodipine, Losartan, Rosuvastatin, and Ezetimibe in Patients with Concomitant Essential Hypertension and Dyslipidemia.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Cholesterol, LDL; Double-Blind Method; Dyslipidemias; Essential Hypertension; Ezetimibe; Humans; Hypertension; Losartan; Rosuvastatin Calcium; Treatment Outcome | 2023 |
Antihypertensive Treatment With β-Blockade in Patients With Asymptomatic Aortic Stenosis and Association With Cardiovascular Events.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Aged, 80 and over; Anticholesteremic Agents; Aortic Valve Stenosis; Asymptomatic Diseases; Blood Pressure; Cause of Death; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Echocardiography, Doppler; Ezetimibe; Female; Heart Ventricles; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Male; Middle Aged; Morbidity; Propensity Score; Simvastatin; Survival Rate; United States | 2017 |
Can group medical clinics improve lipid management in diabetes?
Topics: Adult; Aged; Ambulatory Care Facilities; Anticholesteremic Agents; Azetidines; Cholesterol, HDL; Cholesterol, LDL; Diabetes Complications; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Male; Middle Aged; Treatment Outcome; Veterans | 2014 |
Assessing Optimal Blood Pressure in Patients With Asymptomatic Aortic Valve Stenosis: The Simvastatin Ezetimibe in Aortic Stenosis Study (SEAS).
Topics: Aged; Anticholesteremic Agents; Aortic Valve Stenosis; Blood Pressure; Double-Blind Method; Ezetimibe; Follow-Up Studies; Humans; Hypertension; Middle Aged; Simvastatin | 2016 |
Effect of obesity on left ventricular mass and systolic function in patients with asymptomatic aortic stenosis (a Simvastatin Ezetimibe in Aortic Stenosis [SEAS] substudy).
Topics: Aged; Aged, 80 and over; Angiography; Aortic Valve Stenosis; Azetidines; Body Mass Index; Double-Blind Method; Drug Therapy, Combination; Echocardiography, Doppler; Ezetimibe; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Logistic Models; Male; Middle Aged; Multivariate Analysis; Obesity; Probability; Prognosis; Risk Assessment; Severity of Illness Index; Simvastatin; Stroke Volume; Systole; Treatment Outcome | 2010 |
Lack of clinically relevant drug-drug interactions when dalcetrapib is co-administered with ezetimibe.
Topics: Adolescent; Adult; Aged; Amides; Anticholesteremic Agents; Azetidines; Cross-Over Studies; Drug Administration Schedule; Drug Interactions; Esters; Ezetimibe; Humans; Hypertension; Lipids; Male; Middle Aged; Sulfhydryl Compounds; Young Adult | 2010 |
Hypertension in aortic stenosis: implications for left ventricular structure and cardiovascular events.
Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Antihypertensive Agents; Aortic Valve Stenosis; Azetidines; Blood Pressure; Cardiovascular Diseases; Drug Therapy, Combination; Echocardiography; Ezetimibe; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Simvastatin | 2012 |
Reduction in estimated risk for coronary artery disease after use of ezetimibe with a statin.
Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Azetidines; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Diabetes Mellitus; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Male; Metabolic Syndrome; Middle Aged; Risk | 2007 |
12 other study(ies) available for ezetimibe and Hypertension
| Article | Year |
|---|---|
Hypertension and dyslipidemia treament in stroke.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Brain Ischemia; Calcium Channel Blockers; Cholesterol, LDL; Dyslipidemias; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Indapamide; Stroke | 2022 |
Application of Atorvastatin Combined with Ezetimibe in Elderly Patients with Hypertension Combined with T2DM and Analysis of Significance of Changes in Serum Bilirubin Levels During Treatment.
Topics: Aged; Atorvastatin; Bilirubin; Diabetes Mellitus, Type 2; Ezetimibe; Glucose; Humans; Hypertension | 2023 |
Reducing CV risk in diabetes: An ADA update.
Topics: Antihypertensive Agents; Aspirin; Benzhydryl Compounds; Cardiovascular Diseases; Contraindications; Creatinine; Diabetes Complications; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Drug Chronotherapy; Ezetimibe; Fenofibrate; Glucosides; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Hypolipidemic Agents; Life Style; Liraglutide; Metformin; Niacin; PCSK9 Inhibitors; Platelet Aggregation Inhibitors; Risk Reduction Behavior; Thiazolidinediones | 2017 |
Determinants of inertia with lipid-lowering treatment in patients with type 2 diabetes mellitus.
Topics: Adolescent; Adult; Aged; Anticholesteremic Agents; Antihypertensive Agents; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Drug Tolerance; Dyslipidemias; Ezetimibe; Female; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypolipidemic Agents; Lipids; Male; Middle Aged; Retrospective Studies; Smoking; Young Adult | 2019 |
[The use of complex tools ezetimibe, hepadyfu fosinopril and correction of blood pressure and endothelial dysfunction in patients with nonalcoholic steatohepatitis and essential hypertension stage II].
Topics: Adenine; Anticholesteremic Agents; Azetidines; Carnitine; Drug Combinations; Endothelium, Vascular; Essential Hypertension; Ezetimibe; Fosinopril; Humans; Hypertension; Non-alcoholic Fatty Liver Disease; Obesity; Vascular Diseases | 2014 |
Vascular and metabolic effects of ezetimibe combined with simvastatin in patients with hypercholesterolemia.
Topics: Adiponectin; Aged; Animals; Anticholesteremic Agents; Blood Pressure; C-Reactive Protein; Drug Therapy, Combination; Ezetimibe; Fat Body; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Hypolipidemic Agents; Insulin; Insulin Resistance; Male; Middle Aged; Randomized Controlled Trials as Topic; Rats; Simvastatin; Single-Blind Method | 2015 |
Rhabdomyolysis resulting from pharmacologic interaction between erlotinib and simvastatin.
Topics: Aged; Amlodipine; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Antihypertensive Agents; Aspirin; Atenolol; Azetidines; Carcinoma, Non-Small-Cell Lung; Coronary Artery Disease; Drug Interactions; Erlotinib Hydrochloride; Ezetimibe; Female; Humans; Hyperlipidemias; Hypertension; Lung Neoplasms; Neoplasm Recurrence, Local; Protein Kinase Inhibitors; Quinazolines; Rhabdomyolysis; Simvastatin; Tomography, X-Ray Computed | 2008 |
Safety and efficacy of ezetimibe in a sample of cardiac transplant patients.
Topics: Aged; Alanine Transaminase; Anticholesteremic Agents; Aspartate Aminotransferases; Azetidines; Bilirubin; Cholesterol; Diabetes Mellitus; Dose-Response Relationship, Drug; Dyslipidemias; Ezetimibe; Heart Transplantation; Humans; Hypertension; Immunosuppressive Agents; Middle Aged; Retrospective Studies; Safety; Triglycerides | 2008 |
Asymmetric septal hypertrophy - a marker of hypertension in aortic stenosis (a SEAS substudy).
Topics: Aortic Valve Stenosis; Azetidines; Biomarkers; Cardiomegaly; Cardiomyopathy, Hypertrophic; Ezetimibe; Female; Heart Atria; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Simvastatin | 2010 |
Do functional foods have a role in the prevention of cardiovascular disease?
Topics: Anticholesteremic Agents; Azetidines; Blood Pressure; Cholesterol, Dietary; Dietary Proteins; Ezetimibe; Female; Humans; Hypercholesterolemia; Hypertension; Lipid Metabolism; Male; Milk Proteins; Phytosterols; Soybean Proteins | 2011 |
[Elevated augmentation index].
Topics: Anticholesteremic Agents; Antihypertensive Agents; Azetidines; Bisoprolol; Blood Pressure; Carbazoles; Carvedilol; Drug Costs; Drug Substitution; Evidence-Based Medicine; Ezetimibe; Female; Germany; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Propanolamines; Pulse | 2012 |
New lipid-lowering combo proves successful.
Topics: Atorvastatin; Attitude to Health; Azetidines; Drug Synergism; Drug Therapy, Combination; Europe; Ezetimibe; Heptanoic Acids; Humans; Hypercholesterolemia; Hypertension; Pyrroles; Stroke; Treatment Outcome | 2003 |